Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroimage ; 54(2): 1735-42, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-20728544

ABSTRACT

Poets and philosophers have long acknowledged moral sentiments as key motivators of human social behavior. Prosocial sentiments, which include guilt, pity and embarrassment, enable us to care about others and to be concerned about our mistakes. Functional imaging studies have implicated frontopolar, ventromedial frontal and basal forebrain regions in the experience of prosocial sentiments. Patients with lesions of the frontopolar and ventromedial frontal areas were observed to behave inappropriately and less prosocially, which could be attributed to a generalized emotional blunting. Direct experimental evidence for brain regions distinctively associated with moral sentiment impairments is lacking, however. We investigated this issue in patients with the behavioral variant of frontotemporal dementia, a disorder in which early and selective impairments of social conduct are consistently observed. Using a novel moral sentiment task, we show that the degree of impairment of prosocial sentiments is associated with the degree of damage to frontopolar cortex and septal area, as assessed with 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography, an established measure of neurodegenerative damage. This effect was dissociable from impairment of other-critical feelings (anger and disgust), which was in turn associated with dorsomedial prefrontal and amygdala dysfunction. Our findings suggest a critical role of the frontopolar cortex and septal region in enabling prosocial sentiments, a fundamental component of moral conscience.


Subject(s)
Brain/diagnostic imaging , Emotions/physiology , Frontotemporal Dementia/diagnostic imaging , Morals , Social Behavior , Brain/physiopathology , Brain Mapping , Frontotemporal Dementia/physiopathology , Humans , Image Processing, Computer-Assisted , Neuropsychological Tests , Positron-Emission Tomography
2.
Arch Neurol ; 66(1): 92-6, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19139305

ABSTRACT

BACKGROUND: Formal olfactory testing may be useful as a bedside tool to help differentiate between conditions such as atypical parkinsonism, dementia, and psychiatric conditions. However, the neural basis of olfactory dysfunction, the effect of concurrent cognitive deficits on olfactory testing results, and the exact prevalence of olfactory deficits in populations with corticobasal syndrome (CBS) and the frontal variant of frontotemporal dementia (FTD-FV) are to date unclear. OBJECTIVE: To assess the prevalence and the neural basis of olfactory recognition deficits in patients with a clinical diagnosis of CBS or FTD-FV. DESIGN: Retrospective study of clinical, neuropsychological, and imaging data. SETTING: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. PARTICIPANTS: Twenty-five patients with CBS, 22 with FTD-FV, and 12 age-matched control subjects. MAIN OUTCOME MEASURES: Results of neuropsychological evaluation, formal olfactory recognition testing (University of Pennsylvania Smell Identification Test [UPSIT]), and voxel-based morphometry analysis of structural magnetic resonance images of the brain. RESULTS: Mean UPSIT percentile scores were 31.6% for the CBS group and 9.5% for the FTD-FV group. The voxel-based morphometry correlations between local gray matter and UPSIT scores showed a significant volume effect in the right midfrontal gyrus for the FTD-FV patients and in the right insula, right midfrontal gyrus, and bilateral inferior frontal gyrus for the patients with CBS. A linear regression analysis of the UPSIT scores revealed as significant predictors the general memory score of the Wechsler Memory Scale and the Boston Naming Test total score for the patients with FTD-FV and the Mattis Dementia Rating Scale total score for the patients with CBS. CONCLUSIONS: Our data showed a more severe olfactory impairment for CBS patients than previously reported. We also showed a significant relationship between formal olfactory recognition testing scores and specific cognitive domains. These findings could be useful to clinically differentiate FTD-FV and CBS from other dementing illnesses and movement disorders.


Subject(s)
Dementia/epidemiology , Dementia/physiopathology , Neurodegenerative Diseases/epidemiology , Neurodegenerative Diseases/physiopathology , Olfaction Disorders/epidemiology , Olfaction Disorders/physiopathology , Aged , Atrophy/diagnosis , Atrophy/epidemiology , Atrophy/physiopathology , Brain Mapping , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Cognition Disorders/diagnosis , Cognition Disorders/epidemiology , Cognition Disorders/physiopathology , Comorbidity , Dementia/diagnosis , Disability Evaluation , Disease Progression , Female , Frontal Lobe/pathology , Frontal Lobe/physiopathology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurodegenerative Diseases/diagnosis , Neurologic Examination , Neuropsychological Tests , Olfaction Disorders/diagnosis , Olfactory Pathways/pathology , Olfactory Pathways/physiopathology , Predictive Value of Tests , Prevalence , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...